Literature DB >> 25761964

The survival difference between gastric cancer patients from the UK and Japan remains after weighted propensity score analysis considering all background factors.

Takanobu Yamada1, Takaki Yoshikawa2, Masataka Taguri3, Tsutomu Hayashi1, Toru Aoyama1, Henry M Sue-Ling4, Kiran Bonam5,6, Jeremy D Hayden4, Heike I Grabsch7.   

Abstract

BACKGROUND: Previous studies comparing survival between gastric cancer (GC) patients from the West and the East were based on the assumption that background factors and prognostic factors were identical. The aim of the current study was to compare the survival of GC patients from the UK and Japan using weighted propensity score analysis after identifying all different background factors.
METHODS: Data from 464 patients from the Leeds Teaching Hospital NHS Trust, Leeds, UK (LTHT), and 465 patients from the Kanagawa Cancer Center Hospital, Yokohama, Japan (KCCH), who had surgery for GC were analyzed. Prognostic factors for overall survival (OS) and cancer-specific survival (CSS) were identified by univariate and multivariate analyses. Survival was compared by propensity score weighting after adjusting for all significantly different background factors.
RESULTS: Most background factors were different between LTHT and KCCH patients. Unadjusted stage-specific OS and CSS were significantly better in KCCH. Independent prognostic factors for unadjusted OS and CSS were pT and pN in KCCH and in addition tumor location, pancreatectomy, resection margin status and number of examined lymph nodes in LTHT. Even after adjusting for all background characteristics, survival remained better in KCCH.
CONCLUSIONS: These results suggest that differences in background factors are unable to fully explain the survival difference of GC patients between UK and Japan. Comprehensive studies into the biology of GC and/or host factors are needed to fully understand the survival difference.

Entities:  

Keywords:  East versus West; Gastric cancer; Prognosis; Propensity score weighting

Mesh:

Year:  2015        PMID: 25761964     DOI: 10.1007/s10120-015-0480-5

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  32 in total

Review 1.  The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the suggestions?

Authors:  P A Davis; T Sano
Journal:  Crit Rev Oncol Hematol       Date:  2001-10       Impact factor: 6.312

2.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

Review 3.  Radical surgery for gastric cancer. A review of the Japanese experience.

Authors:  Y Noguchi; T Imada; A Matsumoto; D G Coit; M F Brennan
Journal:  Cancer       Date:  1989-11-15       Impact factor: 6.860

4.  Nodal dissection for patients with gastric cancer: a randomised controlled trial.

Authors:  Chew-Wun Wu; Chao A Hsiung; Su-Shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Anna Fen-Yau Li; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  Lancet Oncol       Date:  2006-04       Impact factor: 41.316

5.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

6.  Cox regression analysis of multivariate failure time data: the marginal approach.

Authors:  D Y Lin
Journal:  Stat Med       Date:  1994-11-15       Impact factor: 2.373

7.  Is gastric carcinoma different between Japan and the United States?

Authors:  Y Noguchi; T Yoshikawa; A Tsuburaya; H Motohashi; M S Karpeh; M F Brennan
Journal:  Cancer       Date:  2000-12-01       Impact factor: 6.860

8.  Clinicopathological study of gastric carcinoma in high- and low-mortality countries: Comparison between Japan and the United States.

Authors:  Michio Maruyama; Kimiya Takeshita; Mitsuo Endo; Mark Deakin; AR Moossa
Journal:  Gastric Cancer       Date:  1998-12       Impact factor: 7.370

9.  Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma.

Authors:  Michael W Kattan; Martin S Karpeh; Madhu Mazumdar; Murray F Brennan
Journal:  J Clin Oncol       Date:  2003-10-01       Impact factor: 44.544

10.  Is the prognosis for Japanese and German patients with gastric cancer really different?

Authors:  E Bollschweiler; K Boettcher; A H Hoelscher; M Sasako; T Kinoshita; K Maruyama; J R Siewert
Journal:  Cancer       Date:  1993-05-15       Impact factor: 6.860

View more
  13 in total

1.  Risk of Lymph Node Metastasis in T1b Gastric Cancer: An International Comprehensive Analysis from the Global Gastric Group (G3) Alliance.

Authors:  Elvira L Vos; Masaya Nakauchi; Mithat Gönen; Jason A Castellanos; Alberto Biondi; Daniel G Coit; Johan L Dikken; Domenico D'Ugo; Henk Hartgrink; Ping Li; Makoto Nishimura; Mark Schattner; Kyo Young Song; Laura H Tang; Ichiro Uyama; Santosha Vardhana; Rob H A Verhoeven; Bas P L Wijnhoven; Vivian E Strong
Journal:  Ann Surg       Date:  2021-12-14       Impact factor: 13.787

Review 2.  Open and minimally invasive gastrectomy in Eastern and Western patient populations: A review of the literature and reasons for differences in outcomes.

Authors:  Mason D Stillman; Sam S Yoon
Journal:  J Surg Oncol       Date:  2022-04-13       Impact factor: 2.885

3.  Higher incidence of pancreatic fistula in laparoscopic gastrectomy. Real-world evidence from a nationwide prospective cohort study.

Authors:  Naoki Hiki; Michitaka Honda; Tsuyoshi Etoh; Kazuhiro Yoshida; Yasuhiro Kodera; Yoshihiro Kakeji; Hikaru Kumamaru; Hiroaki Miyata; Yuichi Yamashita; Masafumi Inomata; Hiroyuki Konno; Yasuyuki Seto; Seigo Kitano
Journal:  Gastric Cancer       Date:  2017-09-08       Impact factor: 7.370

4.  High Hepsin expression predicts poor prognosis in Gastric Cancer.

Authors:  Mingming Zhang; Junjie Zhao; Wenyi Tang; Yanru Wang; Peike Peng; Lili Li; Shushu Song; Hao Wu; Can Li; Caiting Yang; Xuefei Wang; Chunyi Zhang; Jianxin Gu
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

5.  Interleukin-13 receptor α2 is associated with poor prognosis in patients with gastric cancer after gastrectomy.

Authors:  Chao Lin; Hao Liu; Heng Zhang; Hongyong He; He Li; Zhenbin Shen; Jin Qin; Xinyu Qin; Jiejie Xu; Yihong Sun
Journal:  Oncotarget       Date:  2016-08-02

6.  Long-term Trends in Primary Sites of Gastric Adenocarcinoma in Japan and the United States.

Authors:  Michitaka Honda; Sandra L Wong; Mark A Healy; Toshifusa Nakajima; Masayuki Watanabe; Shingo Fukuma; Shunichi Fukuhara; John Z Ayanian
Journal:  J Cancer       Date:  2017-07-05       Impact factor: 4.207

7.  MicroRNA profiles in five pairs of early gastric cancer tissues and adjacent non-cancerous tissues.

Authors:  Yuan Liang; Yongxun Zhao; Longquan Li; Hui Wei; Taobi Huang; Huiyun Zhang; Xia Chen; Heng Yun; Weiming Sun; Yuping Wang
Journal:  Oncol Lett       Date:  2021-06-07       Impact factor: 2.967

8.  The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients.

Authors:  Zhenglin Wang; Hao Liu; Zhenbin Shen; Xuefei Wang; Heng Zhang; Jing Qin; Jiejie Xu; Yihong Sun; Xinyu Qin
Journal:  BMC Cancer       Date:  2015-10-23       Impact factor: 4.430

9.  Apatinib in Advanced Gastric Cancer: A Doubtful Step Forward.

Authors:  Lorenzo Fornaro; Enrico Vasile; Alfredo Falcone
Journal:  J Clin Oncol       Date:  2016-11-01       Impact factor: 44.544

10.  Surgical outcomes of laparoscopic distal gastrectomy compared to open distal gastrectomy: A retrospective cohort study based on a nationwide registry database in Japan.

Authors:  Kazuhiro Yoshida; Michitaka Honda; Hiraku Kumamaru; Yasuhiro Kodera; Yoshihiro Kakeji; Naoki Hiki; Tsuyoshi Etoh; Hiroaki Miyata; Yuichi Yamashita; Yasuyuki Seto; Seigo Kitano; Hiroyuki Konno
Journal:  Ann Gastroenterol Surg       Date:  2017-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.